Nick Scott Ram – Open innovation and drug discovery: New approaches to market exclusivity

‘Open innovation and drug discovery: New approaches to market exclusivity’ Nick Scott-Ram is Director of Commercial development at the Oxford

Read more

Vallon Pharmaceuticals formulating an alternative product to Adderall to limit abuse

Vallon Pharmaceuticals CEO David Baker chatted with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Pennsylvania-based

Read more

Keys to designing a compliant patient assistance program (PAP)

A discussion of how pharmaceutical manufacturers can design patient assistance programs (PAP) to comply with guidelines from the Office of

Read more